glp 1 drugs pancreatitis associated with causing Understanding GLP-1 Agonists

The SUMMIT trial below evaluated the effects of tirzepatide in obese patients with HFpEF

LETO rats, LongEvans Tokushima Otsuka (LETO) rat

Image Credit: siamionau pavel / Shutterstock Background Weight loss reduces obesity-related comorbidities but often leads to decreased bone mineral density (BMD) and increased bone turnover, raising fracture risk and mortality

Many mothers and physicians choose to delay GLP-1 initiation until weaning to eliminate theoretical lactation exposure

"There is no evidence that these drugs are effective at that small amount," said Apovian, who has received grants from Novo Nordisk

Exendin-4 induces cytotoxic autophagy in two ovarian cancer cell lines through inhibition of Mtorc1 mediated by activation of AMPK and suppression of akt